| October 1, 2027 |
NVS |
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas |
Trial Milestone |
Phase 1/Phase 2 |
| October 2, 2027 |
AMGN |
A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus |
Trial Milestone |
Phase 1 |
| October 4, 2027 |
NVO |
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes |
Trial Milestone |
Phase 2 |
| October 7, 2027 |
ARGX |
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP |
Trial Milestone |
Phase 3 |
| October 11, 2027 |
REGN |
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS) |
Trial Milestone |
Phase 4 |
| October 12, 2027 |
MRK |
A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004) |
Trial Milestone |
Phase 2 |
| October 13, 2027 |
SNY |
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration |
Trial Milestone |
Phase 1/Phase 2 |
| October 15, 2027 |
ARGX |
ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis |
Trial Milestone |
Phase 2 |
| October 15, 2027 |
ONC |
A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy |
Trial Milestone |
Phase 2/Phase 3 |
| October 15, 2027 |
NBIX |
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia |
Trial Milestone |
Phase 3 |
| October 15, 2027 |
IBRX |
Study for Participants With Relapsed/Refractory Non-Hodgkin Lymphoma |
Trial Milestone |
Phase 1 |
| October 15, 2027 |
MIRM |
Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM) |
Trial Milestone |
Phase 2 |
| October 15, 2027 |
EYPT |
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME |
Trial Milestone |
Phase 3 |
| October 15, 2027 |
EYPT |
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME |
Trial Milestone |
Phase 3 |
| October 15, 2027 |
PHAR |
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease |
Trial Milestone |
Phase 2 |
| October 15, 2027 |
ORKA |
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis |
Trial Milestone |
Phase 2 |
| October 15, 2027 |
CLYM |
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy |
Trial Milestone |
Phase 2 |
| October 15, 2027 |
SYRE |
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial) |
Trial Milestone |
Phase 2 |
| October 16, 2027 |
IMCR |
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) |
Trial Milestone |
Phase 3 |
| October 20, 2027 |
PHAT |
A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks |
Trial Milestone |
Phase 3 |
| October 24, 2027 |
GSK |
A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China |
Trial Milestone |
Phase 2 |
| October 25, 2027 |
PFE |
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer |
Trial Milestone |
Phase 1/Phase 2 |
| October 29, 2027 |
GSK |
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial |
Trial Milestone |
Phase 3 |
| October 30, 2027 |
ONC |
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma |
Trial Milestone |
Phase 3 |
| October 30, 2027 |
PBYI |
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer |
Trial Milestone |
Phase 2 |
| October 31, 2027 |
BCAX |
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors |
Trial Milestone |
Phase 1 |
| October 31, 2027 |
APLM |
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis |
Trial Milestone |
Phase 2 |